Tenet Healthcare Corp. (NYSE: THC) shares were upgraded to “buy” from “hold” and price target raised to $38 from $31 by Deutsche Bank (DB). “THC’s response to CYH’s overture left a lasting bad taste in our mouths,” the bank wrote. “However, in taking a fresh look at THC, we conclude that its outlook has become more compelling.”[More…]
previous post